Tuesday, February 15, 2022
7 – 8 am
While medullary thyroid cancer remains a surgically treated malignancy, the opportunity for cure is dependent on early diagnosis and treatment. After a brief review of current treatment guidelines, panelists will participate in a semi-structured case-based discussion of disease management focusing on areas of critical importance to management and those that remain controversial.
Join us for a robust discussion based CME with representation from a multidisciplinary team of specialists from endocrinology, pathology and laboratory, medical oncology and surgical oncology.
Moderator: Susan Mandel, MD
Panelists: Virginia LiVolsi, MD, Kate Nathanson, MD, Lova Sun, MD, Rachel Kelz, MD
After participating in this activity, the learner should be able to:
- Describe the diagnostic evaluation for a patient diagnosed with medullary thyroid cancer
- Explain principles of appropriate surgical management
- Discuss evidence-based surveillance strategies
- Review the indications for systemic therapy
BROADCASTMED